{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:41:32Z","timestamp":1786650092547,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Myasthenia gravis (MG) is a neuromuscular junction disorder usually associated with a thymic lesion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objective:<\/jats:title>\n                    <jats:p>To study the clinical, serological, and thymic pathology in patient of MG from this corner of the country.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Method:<\/jats:title>\n                    <jats:p>A retrospective study involving all myasthenia patients presenting to neurology and cardio-thoracic department from the year 2013 to 2020. The clinical findings, Osserman grade of severity, antibodies profile, computed scanning thorax findings and histopathology of the thymic lesion were noted and collected as data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Thirty patients of MG were included with mean age of onset being 39.10 \u00b1 15.77 years which included 22 females and eight males. Four patients had only ocular findings while 26 patients had generalized myasthenia with three patients of respiratory failure. Ach receptor antibodies were positive in 27 patients and negative in two patients. Anti-MUSK was positive in one out of five patients. Abnormal findings in CT thorax seen in 20 patients which included enlarged thymic gland in 11 patients, thymic hyperplasia in two patients, thymoma in four patients, and anterior mediastinal mass in three patients. Thymectomy was done in eighteen patients with thymoma as the most common histopathological findings seen in eight patients, follicular hyperplasia in five patients; other was thymic hyperplasia, thymic cyst, normal thymus gland, and features of sarcoidosis in one patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>MG is a treatable autoimmune disorder with a variety of clinical, radiological, and histopathological findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_617_22","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:25:32Z","timestamp":1671607532000},"page":"7158-7162","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical spectrum of myasthenia gravis: An institute experience over 8 years from North East India"],"prefix":"10.4103","volume":"11","author":[{"given":"Baiakmenlang","family":"Synmon","sequence":"first","affiliation":[{"name":"Department of Neurology, Neigrihms, Shillong, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib","family":"Rawat","sequence":"additional","affiliation":[{"name":"Department of CTVS, Neigrihms, Shillong, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Kynta","sequence":"additional","affiliation":[{"name":"Department of CTVS, Neigrihms, Shillong, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaraf","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neigrihms, Shillong, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shri R.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neigrihms, Shillong, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bifica S.","family":"Lyngdoh","sequence":"additional","affiliation":[{"name":"Department of Pathology, Neigrihms, Shillong, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baphira","family":"Wankhar","sequence":"additional","affiliation":[{"name":"Department of Radiology, Neigrihms, Shillong, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen","family":"Hynniewta","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neigrihms, Shillong, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4103\/0301-4738.145987","article-title":"Ocular myasthenia gravis:A review","volume":"62","author":"Nair","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"R2-20260109","year":"2016","journal-title":"NINDS"},{"key":"R3-20260109","article-title":"Myasthenia gravis. Genetics Home Reference","journal-title":"Archived from the original on 11 July 2015"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis, prevalence, clinical correlates and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"R5-20260109","first-page":"CD008111","article-title":"Thymectomy for non-thymomatous myasthenia gravis","author":"Cea","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in Myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11940-005-0022-2","article-title":"An update on myasthenic crisis","volume":"7","author":"Ahmed","year":"2005","journal-title":"Curr Treat Options Neurol"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.1956.02960380001001","article-title":"Studies in myasthenia gravis\u2014A rapid diagnostic test. Further progress with edrophonium (Tensilon) hydrochloride","volume":"160","author":"Osserman","year":"1956","journal-title":"JAMA"},{"key":"R11-20260109","article-title":"Overview of the treatment of Myasthenis Gravis","author":"Bird","year":"2022","journal-title":"Upto date"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4103\/0028-3886.43455","article-title":"Myasthenia gravis:A study from India","volume":"56","author":"Singhal","year":"2008","journal-title":"Neurol India"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/123.4.665","article-title":"The incidence and life timeprevalence of neurological disorders in a prospective community-based study","volume":"123","author":"MacDonald","year":"2000","journal-title":"Brain"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jnnp.71.3.352","article-title":"Epidemiology of seropositive myasthenia gravis in Greece","volume":"71","author":"Poulas","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/pgmj.2004.018903","article-title":"Update on myasthenia gravis","volume":"80","author":"Thanvi","year":"2004","journal-title":"Postgrad Med J"},{"key":"R16-20260109","first-page":"35","article-title":"Myasthenia gravis in Singapore","volume":"8","author":"Lok","year":"2003","journal-title":"Neuro J Southeast Asia"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","article-title":"Myasthenia gravis (MG):Epidemiolological data and prognostic factors","volume":"998","author":"Mantegazza","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"R18-20260109","first-page":"933","article-title":"Clinical profile of myasthenia gravis","volume":"46","author":"Saha","year":"1998","journal-title":"J Physcians India"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.65.4.492","article-title":"Myasthenia gravis:A population based epidemiological study in Cambridgeshire, England","volume":"65","author":"Robertson","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0404.1992.tb05050.x","article-title":"Myasthenia gravis in Hong Kong Chinese, 1:Epidemiology and adult disease","volume":"86","author":"Yu","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"R21-20260109","first-page":"20","article-title":"A clinicopathological study of mediastinal masses operated in a tertiary care hospital in Eastern India in 3 years with special reference to thymoma","volume":"59","author":"Das","year":"2016","journal-title":"Indian J Pathol Microbiol"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01215447","article-title":"Ocular myastheniagravis. A critical review of clinical and pathophysiological aspects","volume":"84","author":"Sommer","year":"1993","journal-title":"Doc Ophthalmol"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5005\/jp-journals-10071-23320","article-title":"Successfully treated hepatitis B positive refractory myasthenic crisis with rituximab","volume":"24","author":"Singh","year":"2020","journal-title":"Indian J Crit Care Med"},{"key":"R24-20260109","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/0972-5229.83009","article-title":"Critical illness myopathy and polyneuropathy-A challenge for physiotherapists in the intensive care units","volume":"15","author":"Pattanshetty","year":"2011","journal-title":"Indian J Crit Care Med"},{"key":"R25-20260109","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nature Med"},{"key":"R26-20260109","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3988\/jcn.2011.7.4.173","article-title":"Treatment of myasthenia gravis based on its immunopathogenesis","volume":"7","author":"Kim","year":"2011","journal-title":"J Clin Neurol"},{"key":"R27-20260109","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9610(83)90260-X","article-title":"Thymectomy for myasthenia gravis","author":"Mulder","year":"1983","journal-title":"Am J Surg"},{"key":"R28-20260109","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1510\/icvts.2004.097246","article-title":"CT and myasthenia gravis:Correlation between mediastinal imaging and histopathological findings","volume":"4","author":"de","year":"2005","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R29-20260109","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13760-019-01102-w","article-title":"A study of comorbidities in myasthenia gravis","volume":"120","author":"Misra","year":"2020","journal-title":"Acta Neurol Belg"},{"key":"R30-20260109","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of Myasthenia gravis 2020 update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_617_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:02:07Z","timestamp":1786647727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_617_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_617_22","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"2022-03-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}